Skip to main content

Pharmacy

By Susan Morse | 01:51 pm | April 25, 2017
Insurer is engaging in a request for proposals for a new pharmacy benefit manager following the end of its contract.
By Beth Jones Sanborn | 03:42 pm | April 24, 2017
Leaders consistently included shortages and drug pricing among their top concerns in the survey over the last two years.
By Kaiser Health News | 10:39 am | April 24, 2017
Patent laws, government incentives, meant to encourage development of less-profitable drugs, enable some companies to get a leg up, set high prices.
By Kaiser Health News | 10:11 am | April 24, 2017
Congressional records show those eight, including Celgene and Mylan, kicked in an extra $4.42 million versus that quarter last year.
By Kaiser Health News | 09:42 am | April 24, 2017
News of Marathon's resignation comes after wide criticism for $89,000 price tag for Emflaza, a drug for Duchenne muscular dystrophy drug.
By Bernie Monegain | 01:42 pm | April 21, 2017
Hospitals, doctors' practices, government, insurers, and healthcare IT companies could all be affected, Kalorama says.
By Jeff Lagasse | 02:52 pm | April 20, 2017
Use of prescription drugs in Medicaid was lower in states with medical marijuana laws; estimated savings totaled about $1.01 billion.
By Kaiser Health News | 11:27 am | April 19, 2017
PhRMA Senior VP Scott LaGanga led Partnership for Safe Medicines, which recently emerged as leading voice against bills allow drug imports.
By Kaiser Health News | 09:55 am | April 17, 2017
Proposal would levy the tax directly on opioid manufacturers and wholesalers, who would pay 1 cent per milligram at the first point of sale.
By Beth Jones Sanborn | 03:46 pm | April 14, 2017
Dubbed 'Operation Avalanche,' alleged fraud ring involved three Brooklyn clinics that spawned illegal oxycodone prescriptions, fraudulent Medicare claims.